Senior insider sale
EVP, Chief Scientific Officer at VERTEX PHARMACEUTICALS INC / MA — senior position signals high conviction
$3.00M
6.28K shares
What this filing means
BUNNAGE MARK E. plans to sell 6.28K shares of VERTEX PHARMACEUTICALS INC / MA valued at approximately $3.00M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/25/2026ACC: 0001959173-26-001472
Officer· EVP, Chief Scientific Officer
Since Feb 2026
6.28K
Shares to sell
$3.00M
Approx. market value
620.00
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
2/24/2026
620.00Total acquired620.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/24/2026 | Restricted Stock Vesting Compensation | 620.00 | — |
| Total | 620.00 | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
1.18K
Market value
$559.9K
2/18/2026
—Completed
Units to sell
2.44K
Market value
$1.19M
2/17/2026
—Completed
Units to sell
2.02K
Market value
$930.5K
2/11/2026
—Completed
Units to sell
23.00
Market value
$10.6K
12/29/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
620.00
Market value
$301.5K
2/25/2026
Total
Units
6.28K
Value
$3.00M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/18/2026 | 1.18K | $559.9K | — | Completed |
2/17/2026 | 2.44K | $1.19M | — | Completed |
2/11/2026 | 2.02K | $930.5K | — | Completed |
12/29/2025 | 23.00 | $10.6K | — | Completed |
| Planned — Approximate Date | ||||
2/25/2026 | 620.00 | $301.5K | NASDAQ | Planned |
| Total | 6.28K | $3.00M | ||